Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0
Basic Information
- Primary DI
- 05204309137114
- Basic UDI-DI Code
- B-05204309137114
- Reference
- 1417-0550
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Medicon Hellas SA
Additional Description
Reagents for In Vitro quantitative automated measurement of the concentration of Apolipoprotein A1 - ApoA1, by trained laboratory professionals, in samples of human serum from the general patient population. Measurements of ApoA1 are to be used along with other in vitro and in vivo tests and physical examination by licensed physicians, as a direct and indirect aid to screening, diagnosis, management and risk assessment of atherosclerotic cardiovascular disease (ASCVD). This product has been packed for use with SIEMENS ADVIA® 1800/2400/XPT analyzers.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0102010401 | APOLIPOPROTEIN A I |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).
BluBox
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries
ViroTrack Sero COVID-19 Total Ab
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURETM Haemoglobin F and A2 Calibrators
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ Haemoglobin F and A2 Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries